Eiffel's New SCF Facility in Operation.
Non Bactericidal Antibiotics.
C-Pulse Heart Device Testing Progressing.
Mesoblast Boosted by Successful Closing of IPO.
China's Changing IPR Landscape.
Investment Hotspot: China's OTC Market.
Matrix Laboratories Close to Inking Landmark Contract Manufacturing Deal.
Sosei US Subsidiary Focuses on CNS Therapy Development.
Novartis Contemplates Setting up Research Base in India.
Latest Pharma Merger: Dainippon and Sumitomo.
Eisai Targets on Anti-Hepatitis Drug Market in China.
Zimmer Targets at Asian Aging Population.
ES Cell Receives Million Dollar Grant.
Combing to be Regional Vaccine Manufacturing Center.